Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-14-000360

← back to feed
Filed
May 9, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 7, 2014 14.84M sh
Capex Q1 2014 · Mar 31, 2014 $230.73K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$3.77M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$38.52K
Stockholders Equity Q1 2014 · Mar 31, 2014 $328.15K
Stockholders Equity Q1 2014 · Dec 31, 2013 −$184.05K
Stockholders Equity restated Q1 2014 · Mar 31, 2013 −$184.05K
Current Liabilities Q1 2014 · Mar 31, 2014 $167.47K
Current Liabilities restated Q1 2014 · Mar 31, 2013 $191.24K
Total Liabilities Q1 2014 · Mar 31, 2014 $180.47K
Total Liabilities restated Q1 2014 · Mar 31, 2013 $207.24K
Current Assets Q1 2014 · Mar 31, 2014 $502.8K
Current Assets restated Q1 2014 · Mar 31, 2013 $18.99K
Total Assets Q1 2014 · Mar 31, 2014 $508.62K
Total Assets restated Q1 2014 · Mar 31, 2013 $23.2K
Eps Basic Q1 2014 · Mar 31, 2014 −$0.01
Eps Basic Q1 2014 · Mar 31, 2013 −$0.01
Sga Expense Q1 2014 · Mar 31, 2014 $5.73M
Sga Expense Q1 2014 · Mar 31, 2013 $96.05K
Rd Expense Q1 2014 · Mar 31, 2014 $2.28M
Rd Expense Q1 2014 · Mar 31, 2013 $4.64K
Net Income Q1 2014 · Mar 31, 2014 −$9.87M
Net Income Q1 2014 · Mar 31, 2013 −$103.12K
Cash And Equivalents Q1 2014 · Mar 31, 2013 $719
Cash And Equivalents Q1 2014 · Dec 31, 2012 $1.04K